Total Payments
$5,028
2024 Payments
$1,278
Companies
18
Transactions
255
Medicare Patients
3,505
Medicare Billing
$219,767
Payment Breakdown by Category
Food & Beverage$4,835 (96.2%)
Education$192.70 (3.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,835 | 251 | 96.2% |
| Education | $192.70 | 4 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,346 | 92 | $0 (2024) |
| Janssen Biotech, Inc. | $1,084 | 39 | $0 (2024) |
| PFIZER INC. | $663.42 | 43 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $528.07 | 18 | $0 (2024) |
| Incyte Corporation | $458.37 | 24 | $0 (2024) |
| LEO Pharma Inc. | $289.77 | 11 | $0 (2023) |
| UCB, Inc. | $103.97 | 3 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $94.76 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $91.88 | 4 | $0 (2024) |
| Amgen Inc. | $85.81 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,278 | 55 | E.R. Squibb & Sons, L.L.C. ($321.08) |
| 2023 | $2,022 | 91 | Janssen Biotech, Inc. ($404.50) |
| 2022 | $678.45 | 44 | ABBVIE INC. ($340.52) |
| 2021 | $1,049 | 65 | AbbVie Inc. ($391.74) |
All Payment Transactions
255 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Immunology | ||||||
| 07/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.72 | General |
| Category: Immunology | ||||||
| 07/08/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 06/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: DERMATOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: DERMATOLOGY | ||||||
| 06/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Immunology | ||||||
| 06/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $36.44 | General |
| Category: Immunology | ||||||
| 06/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Immunology | ||||||
| 06/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.61 | General |
| Category: Immunology | ||||||
| 05/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Immunology | ||||||
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.25 | General |
| Category: Immunology | ||||||
| 05/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Immunology | ||||||
| 05/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.48 | General |
| Category: Immunology | ||||||
| 05/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.19 | General |
| Category: Immunology | ||||||
| 05/07/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $26.83 | General |
| Category: DERMATOLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,087 | 1,603 | $409,827 | $65,933 |
| 2022 | 11 | 786 | 1,129 | $221,407 | $47,596 |
| 2021 | 13 | 1,175 | 1,809 | $253,279 | $78,146 |
| 2020 | 9 | 457 | 744 | $89,462 | $28,092 |
Total Patients
3,505
Total Services
5,285
Medicare Billing
$219,767
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 359 | 478 | $144,834 | $25,979 | 17.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 146 | 162 | $63,504 | $9,828 | 15.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 102 | 120 | $53,520 | $8,425 | 15.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 139 | 177 | $47,790 | $6,328 | 13.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $33,101 | $5,012 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 48 | $20,736 | $3,836 | 18.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 81 | 86 | $16,254 | $2,957 | 18.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 90 | 387 | $13,932 | $1,703 | 12.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 37 | 46 | $9,936 | $1,430 | 14.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $6,220 | $435.68 | 7.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 253 | 318 | $78,023 | $17,306 | 22.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 85 | 98 | $28,151 | $6,286 | 22.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 77 | 85 | $27,822 | $6,274 | 22.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 101 | 122 | $24,335 | $4,257 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 56 | $19,128 | $4,028 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 41 | 41 | $12,581 | $2,400 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $7,879 | $1,770 | 22.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 70 | 286 | $7,059 | $1,367 | 19.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 24 | 36 | $5,231 | $1,334 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 40 | 43 | $5,959 | $1,330 | 22.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 28 | 28 | $5,241 | $1,243 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 264 | 347 | $66,454 | $21,138 | 31.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 94 | 125 | $30,444 | $10,009 | 32.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 138 | 138 | $32,447 | $9,824 | 30.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 128 | 143 | $31,908 | $9,747 | 30.5% |
About Jessica Runquist, PA-C
Jessica Runquist, PA-C is a Physician Assistant healthcare provider based in Swansea, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2017. The National Provider Identifier (NPI) number assigned to this provider is 1124557376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Runquist, PA-C has received a total of $5,028 in payments from pharmaceutical and medical device companies, with $1,278 received in 2024. These payments were reported across 255 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,835).
As a Medicare-enrolled provider, Runquist has provided services to 3,505 Medicare beneficiaries, totaling 5,285 services with total Medicare billing of $219,767. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Swansea, MA
- Active Since 06/09/2017
- Last Updated 12/13/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1124557376
Products in Payments
- SKYRIZI (Biological) $834.65
- TREMFYA (Drug) $767.96
- EUCRISA (Drug) $529.02
- Sotyktu (Drug) $528.07
- OPZELURA (Drug) $458.37
- REMICADE (Biological) $315.71
- RINVOQ (Biological) $299.62
- ADBRY (Biological) $198.21
- HUMIRA (Biological) $170.70
- CIBINQO (Drug) $111.70
- Bimzelx (Biological) $103.97
- ENSTILAR (Drug) $91.56
- DUPIXENT (Biological) $88.44
- Otezla (Drug) $85.81
- COSENTYX (Drug) $48.49
- TALTZ (Drug) $42.64
- DUOBRII (Drug) $37.40
- AMELUZ (Drug) $26.83
- VTAMA (Drug) $24.88
- OLUMIANT (Drug) $23.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Swansea
Jennifer Adams, Pa, PA
Physician Assistant — Payments: $26,442
Physician Assistant $26,442
Molly Braddock, Pa-C, PA-C
Physician Assistant — Payments: $8,896
Physician Assistant $8,896
Elizabeth Ridley, Pa, PA
Physician Assistant — Payments: $8,895
Physician Assistant $8,895
Alisia Schmidt, Pa-C, PA-C
Physician Assistant — Payments: $573.10
Physician Assistant $573.10
Margaret Inacio, Pa-C, PA-C
Physician Assistant — Payments: $157.09
Physician Assistant $157.09
Dawn Santos, Pa, PA
Physician Assistant — Payments: $85.66
Physician Assistant $85.66